Selected article for: "acute phase and long lasting"
Author: Invernizzi, Alessandro; Schiuma, Marco; Parrulli, Salvatore; Torre, Alessandro; Zicarelli, Federico; Colombo, Valeria; Marini, Sara; Villella, Elena; Bertoni, Alice; Antinori, Spinello; Rizzardini, Giuliano; Galli, Massimo; Meroni, Luca; Giacomelli, Andrea; Staurenghi, Giovanni
Title: Retinal vessels modifications in acute and post-COVID-19
  • Cord-id: z500ecau
  • Document date: 2021_9_29
    • ID: z500ecau
    Snippet: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-CoV-2 primarily affecting the respiratory system which can damage vessels walls virtually in any body district. Changes affecting retinal vessels are a good marker for systemic vascular alterations. This study investigated retinal vessels during the acute phase of COVID-19 and after patients recovery. Fifty-nine eyes from 32 COVID-19 patients and 80 eyes from 53 unexposed subjects were included. Mean arteries diameter (M
    Document: Coronavirus disease 2019 (COVID-19) is an infectious disease caused by SARS-CoV-2 primarily affecting the respiratory system which can damage vessels walls virtually in any body district. Changes affecting retinal vessels are a good marker for systemic vascular alterations. This study investigated retinal vessels during the acute phase of COVID-19 and after patients recovery. Fifty-nine eyes from 32 COVID-19 patients and 80 eyes from 53 unexposed subjects were included. Mean arteries diameter (MAD) and mean veins diameter (MVD) were assessed through semi-automatic analysis on fundus color photos at baseline and 6 months later in patients and subjects unexposed to the virus. At baseline MAD and MVD were significantly higher in COVID-19 patients compared to unexposed subjects (p < 0.0001). Both MAD and MVD significantly decreased in COVID-19 patients at follow-up (from 97.5 ± 10.9 to 92.2 ± 11.4 µm, p < 0.0001 and from 133.1 ± 19.3 to 124.6 ± 16.1 µm, p < 0.0001, respectively). Despite this reduction vessels diameter remained significantly higher in severe COVID-19 patients compared to unexposed subjects. Transient retinal vessels dilation could serve a biomarker for systemic inflammation while long-lasting alterations seen in severe COVID-19 likely reflect irreversible structural damage to the vessels walls and should be further investigated for their possible effects on tissues perfusion and function.

    Search related documents:
    Co phrase search for related documents
    • absolute number and acute phase: 1
    • absolute number and acute respiratory distress syndrome: 1, 2, 3, 4
    • absolute number and acute respiratory sars syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • absolute number and long acute: 1
    • absolute number and longitudinal study: 1
    • acute patient and long acute: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • acute patient and longitudinal study: 1, 2, 3, 4, 5
    • acute patient and lung parenchyma: 1, 2, 3, 4, 5, 6
    • acute phase and long acute: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute phase and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute phase and lung parenchyma: 1, 2, 3, 4
    • acute respiratory distress syndrome and long acute: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome and longitudinal study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • acute respiratory distress syndrome and luigi sacco: 1
    • acute respiratory distress syndrome and lung parenchyma: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory distress syndrome lead and long acute: 1
    • acute respiratory distress syndrome lead and lung parenchyma: 1, 2
    • acute respiratory sars syndrome and local ethic committee: 1
    • acute respiratory sars syndrome and long acute: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25